Jungmin Jo, Ahrong Ham, Kyoung Eun Lee, Dong Hyeon Lee. "Pre-progression discontinuation and off-treatment progression-free interval after enfortumab vedotin–based therapy among patients with clinical benefit in advanced urothelial carcinoma: A single-institution experience.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16593